LENZ Therapeutics (LENZ) Leases (2021 - 2026)

LENZ Therapeutics (LENZ) reported Leases of $619000.0 for Q1 2026, down 42.1% year-over-year from $1.1 million in Q1 2025, and down 15.67% on a QoQ basis from $734000.0 in Q4 2025.

LENZ Therapeutics (LENZ) has 6 years of Leases data on file, last reported at $619000.0 in Q1 2026.

  • Quarterly Leases fell 42.1% year-over-year to $619000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $619000.0 (down 42.1% YoY) and the FY2025 annual result came in at $734000.0, down 45.14% from the prior year.
  • Leases eased to $619000.0 in Q1 2026 per LENZ's latest filing, from $734000.0 in the prior quarter.
  • Across five years, Leases topped out at $15.8 million in Q2 2023 and bottomed at $318000.0 in Q4 2023.
  • The 5-year median for Leases is $1.5 million (2024), against an average of $4.4 million.
  • The widest annual swing landed in 2023, when Leases tumbled 94.3%; it then soared 320.75% in 2024.
  • Tracing LENZ's Leases over 5 years: stood at $5.6 million in 2022, then plunged by 94.3% to $318000.0 in 2023, then jumped by 320.75% to $1.3 million in 2024, then sank by 45.14% to $734000.0 in 2025, then decreased by 15.67% to $619000.0 in 2026.
  • Per Business Quant, the three latest LENZ Leases figures stand at $619000.0 (Q1 2026), $734000.0 (Q4 2025), and $847000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 LENZ Therapeutics 235.77 Mn 235.77 Mn 825,000.00 619,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 619,000.00
Dec 31, 2025 734,000.00
Sep 30, 2025 847,000.00
Jun 30, 2025 959,000.00
Mar 31, 2025 1.07 Mn
Dec 31, 2024 1.34 Mn
Sep 30, 2024 1.53 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 578,000.00
Dec 31, 2023 318,000.00
Sep 30, 2023 13.20 Mn
Jun 30, 2023 15.84 Mn
Mar 31, 2023 4.01 Mn
Dec 31, 2022 5.58 Mn
Sep 30, 2022 7.12 Mn
Jun 30, 2022 8.64 Mn
Mar 31, 2022 10.12 Mn
Dec 31, 2021 11.57 Mn
Sep 30, 2021 9.08 Mn